14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 RLMD stock ended at $3.83. This is 0.262% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 5.32% from a day low at $3.75 to a day high of $3.95.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Relmada Therapeutics, Inc. prices

Date Open High Low Close Volume
Jul 24, 2023 $2.89 $2.90 $2.76 $2.84 98 686
Jul 21, 2023 $2.97 $3.03 $2.85 $2.89 92 893
Jul 20, 2023 $2.74 $3.04 $2.74 $2.97 200 480
Jul 19, 2023 $2.77 $2.95 $2.73 $2.75 81 617
Jul 18, 2023 $2.85 $2.94 $2.75 $2.78 60 377
Jul 17, 2023 $2.82 $2.90 $2.78 $2.84 62 458
Jul 14, 2023 $2.82 $2.93 $2.72 $2.84 76 060
Jul 13, 2023 $2.95 $2.98 $2.81 $2.82 91 087
Jul 12, 2023 $2.77 $2.95 $2.69 $2.91 143 702
Jul 11, 2023 $2.70 $2.85 $2.65 $2.70 86 158
Jul 10, 2023 $2.52 $2.71 $2.52 $2.66 133 643
Jul 07, 2023 $2.51 $2.55 $2.44 $2.49 85 117
Jul 06, 2023 $2.59 $2.65 $2.48 $2.50 155 148
Jul 05, 2023 $2.51 $2.61 $2.51 $2.60 86 106
Jul 03, 2023 $2.47 $2.56 $2.47 $2.53 69 026
Jun 30, 2023 $2.52 $2.57 $2.46 $2.46 67 272
Jun 29, 2023 $2.47 $2.64 $2.46 $2.49 120 884
Jun 28, 2023 $2.43 $2.48 $2.36 $2.45 111 558
Jun 27, 2023 $2.46 $2.51 $2.41 $2.42 87 241
Jun 26, 2023 $2.50 $2.59 $2.44 $2.47 198 117
Jun 23, 2023 $2.56 $2.59 $2.40 $2.47 2 863 723
Jun 22, 2023 $2.68 $2.72 $2.53 $2.56 158 379
Jun 21, 2023 $2.86 $2.86 $2.54 $2.73 214 866
Jun 20, 2023 $2.60 $2.99 $2.49 $2.86 323 981
Jun 16, 2023 $2.58 $2.67 $2.42 $2.60 301 207
Click to get the best stock tips daily for free!

About Relmada Therapeutics, Inc.

Relmada Therapeutics. Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder ... RLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT